Lakeshore Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Lakeshore Capital Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$686K	Buy	1,396 +14	+1%	+$7.6K	0.56%	51
2025 Q4	$801K	Buy	1,382 +30	+2%	+$17K	0.64%	47
2025 Q3	$656K	Buy	1,352 +22	+2%	+$10.2K	0.53%	57
2025 Q2	$539K	Buy	1,330 +398	+43%	+$166K	0.48%	62
2025 Q1	$464K	Buy	932 +37	+4%	+$20K	0.45%	64
2024 Q4	$466K	Buy	+895	New	+$492K	0.7%	47

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lakeshore Capital Group's TMO Position: Q1 2026 in Review

Lakeshore Capital Group increased its Thermo Fisher Scientific (TMO) stake by 1% in Q1 2026, buying an estimated $7.6K and bringing the position to 1,396 shares worth $686K. The position accounts for 0.56% of the portfolio, ranked #51.

Lakeshore Capital Group first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $801K in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Lakeshore Capital Group held 1,396 shares of Thermo Fisher Scientific worth $686K as of Q1 2026.
Lakeshore Capital Group bought 14 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.6K.
Thermo Fisher Scientific made up 0.56% of Lakeshore Capital Group's portfolio in Q1 2026, its #51 holding.
Lakeshore Capital Group first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
Lakeshore Capital Group's Thermo Fisher Scientific position peaked at $801K in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Lakeshore Capital Group's 13F filing for Q1 2026, filed 22 Apr 2026.